Athersys: Here’s What Investors Need to Know Before Earnings

Athersys (NASDAQ:ATHX) will report earnings after markets close on Tuesday, May 14th. Athersys Incorporated is a biotechnology company. The Company has developed technologies that will help identify gene and related proteins and create synthetic human chromosomes.

Here is your Cheat Sheet to Athersys Earnings:

Earnings Expectations: Analysts expect earnings of $-0.11 per share on revenues of $1.58 million.

Analyst Trends:

Analysts have a more negative outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has fallen from a loss of $0.06 to a loss $0.12. For the current year, the average estimate is a loss of $0.35, which is better than the estimate ninety days ago.

Earnings Trends:

Here’s how Athersys has been performing on an annual basis:

Fiscal Year 2008 2009 2010 2011 2012
Revenue ($) in millions 3.11 2.16 8.94 10.34 8.71
Diluted EPS ($) -0.95 -0.81 -0.60 -0.59 -0.45

Next, our CHEAT SHEET investing framework asks us to drill down to the recent quarterly data:

Quarter Dec. 31, 2011 Mar. 31, 2012 Jun. 30, 2012 Sep. 30, 2012 Dec. 31, 2012
Revenue ($) in millions 2.57 2.75 2.66 1.02 2.29
Diluted EPS ($) -0.1767 -0.17 -0.13 -0.12 -0.0712

Past Performance:
Athersys has beat analyst estimates 3 times in the past four quarters. Shareholders could expect a boost if the company beats estimates.

“E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our successful CHEAT SHEET investing framework. Don’t waste another minute – click here to discover our CHEAT SHEET stock picks now!

(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at]